Skip to content
lifestyle.onebyfourstudio.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
OKYO Pharma LTD
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
October 6, 2026
OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences
September 29, 2026
OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026
September 9, 2026
OKYO Pharma to Speak at Cantor Global Healthcare Conference
September 8, 2026
OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer
July 28, 2026
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026
July 27, 2026
OKYO Pharma Announces Purchase of Shares by Director
July 23, 2026
OKYO Pharma Announces Purchase of Shares by Chief Executive Officer
July 23, 2026
OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD
May 24, 2026
OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May
May 21, 2026
1
2
Next Page
→